# A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

> **NCT07248839** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Volunteers
- Hepatic Impairment

## Interventions

- **DRUG:** BMS-986435

## Key facts

- **NCT ID:** NCT07248839
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2026-04-06
- **Final completion:** 2026-04-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07248839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07248839, "A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT07248839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*